Trial Profile
The Efficacy of sitafloxacin in the elderly patients with pneumonia (included Nursing and Healthcare-Associated Pneumonia, aspiration pneumonia: NHCAP and aspiration pneumonia);a randomized controlled study of sitafroxacin and garenoxacin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jul 2019
Price :
$35
*
At a glance
- Drugs Sitafloxacin (Primary) ; Garenoxacin
- Indications Aspiration pneumonia; Pneumonia
- Focus Therapeutic Use
- 09 Jul 2019 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan (UMIN000012627)
- 17 Feb 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan (UMIN000012627)
- 29 Jan 2014 New trial record